Current and future strategies to block tumor angiogenesis, invasion, and metastasis

World Journal of Urology

Volumn 14, Issue 3, 1996, Pages 131-140

  Effort, P J ^a   Gast, G ^a   Strohmeyer, T ^b  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; CANCER INVASION; HUMAN; METASTASIS; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); ONCOLOGY; REVIEW; VASCULARIZATION;

ANIMALS; HUMANS; MEDICAL ONCOLOGY; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC;

EID: 0029683280     PISSN: 07244983     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (81)

1. Albelda SM, Oliver PD, Romer LH, Buck CA (1990) EndoCAM: a novel endothelial cell cell adhesion molecule. J Cell Biol 110:1227-1237
2. Arteaga CL, Hurd S, Winnier A, Johnson M, Fendly B, Forbes J (1993) Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. J Clin Invest 92:2569-2576
3. Augustin HG, Kozian DH, Johnson RC (1994) Differentiation of endothelial cells: analysis of the constitutive and activated endothelial cell phenotypes. Bioessays 16:901-906
4. Bauer W, Igot JP, Le Gal Y (1975) Chronologie du cancer mammaire utilisant un modele de croissance de Gompertz. Bull Cancer 62:341-358
5. Bicknell R, Harris A (1992) Anticancer strategies involving the vasculature: vascular targeting and the inhibition of angiogenesis. Semin Cancer Biol 3:399-407
6. Brem H, Gressner I, Grosfeld J. Folkman J (1993) The combination of antiangiogenic agents to inhibit primary tumor growth and metastasis. J Pediatr Surg 28: 1253-1257
7. Brem S, Zagzag D, Tsanadis AM, Gately S, Elkouby MP, Brien SE ( 1990) Inhibition of angiogenesis and tumor growth in the brain. Am J Pathol 137: 1121-1 142
8. Brouty-Boye D, Zetter BR (1980) Inhibition of cell motility by interferon. Science 208:516-518
9. Chiarugi V, Ruggiero M (1984) Cooperative effect of cortisone and heparin in the control of plasminogen activator. Ital J Biochem 33: 142 A
10. Crum R, Szabo S, Folkman J (1985) A new class of steroids inhibits angiogenesis in the presence of heparin or a heparin fragment. Science 230: 1375-1378
11. DeCIerck YA, Ferez N, Shimada H, Boone TC, Langley KE, Taylor SM (1992) Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases. Cancer Res 52:701-708
12. Fidler U, Hart IR (1982) Biological diversity in metastatic neoplasms: origins and implications. Science 217:998-1001
13. Folkman J, Weisz PB, Joullie MM, Li WW, Ewing WR (1989) Control of angiogenesis with synthetic heparin substitutes. Science 243:1490-1493
14. Gasic GJ (1984) Role of plasma, platelets and endothelial cells in tumour metastasis. Cancer Metastasis Rev 3:99-114
15. Gross J, Azizkhan RG, Biswas C, Bruns R, Hseih D, Folkmann J (1981) Inhibition of tumor growth, vascularization and collagenolysis in the rabbit cornea by medroxyprogesterone. Proc Natl Acad Sci USA 78: 1176-1180
16. Guirguis R, Margulies I, Taraboletti G, Schiffmann E, Liotta L (1987) Cytokine induced pseudopodial protrusion is coupled to tumour cell migration. Nature 329:261-263
17. Guirguis R, Schiffmann E, Liu B, Birkbeck D, Engel J, Liotta L (1988) Detection of autocrine motility factor in urine as a marker of bladder cancer. J Natl Cancer Inst 80: 1203-1211
18. Gutkind J, Novotny E, Brann M, Robbins K (1991) Muscarinic acetylcholine receptor subtypes as agonist-dependent oncogenes. Proc Natl Acad Sci USA 88:4703-4707
19. Hardan I, Weiss L, Hershkoviz R, Greenspoon N, Alon R, Cahalon L, Reich S, Slavin S, Lider O (1993) Inhibition of metastatic cell colonization in murine lungs and tumor-induced morbidity by non-peptidic ARG-GLY-ASP mimetics. Int J Cancer 55:1023-1028
20. Hart IR (1991) Adhesion proteins and receptors in solid tumour metastasis: melanoma as a model. In: Borden EC (ed) The metastatic cascade: scope for intervention. Mediscript, London, pp 27-410
21. Hennessy C, Henry J, May FEB, Wesdey BR, Angus B, Lennard TW (1991) Expression of the antimetastatic gene nm23 in human breast cancer: an association with good prognosis. J Natl Cancer Inst 83:281-285
22. Henry JA, McCarthy AL, Angus B, Westley BR, May FEB, Nicholson S, Cairns J, Harris AL, Hörne CHW (1990) Prognostic significance of the estrogen-regulated protein, cathepsin D, in breast cancer. An immunohistochemical study. Cancer 65:265-271
23. Hollas W, Blasi F, Boyd D (1991) Role of the urokinase receptor in facilitating extracellular matrix invasion by cultured colon cancer. Cancer Res 51:3690-3695
24. Honn K, Bockman R, Marnett L (198I) Prostaglandins and cancer: a review of tumor initiation through tumor metastasis. Prostaglandin 21:833-864
25. Hori A, Sasada R, Matsutanti E, Naito K, Sakura Y, Fujita T, Kozai Y (1991) Suppression of solid tumor growth by immunoneutralizing monoclonal antibody against human basic fibroblast growth factor. Cancer Res 51:6180-6184
26. Ingber DE, Madri JA, Folkman J (1986) A possible mechanism for inhibition of angiogenesis by angiostatic steroids: induction of capillary basement membrane dissolution. Endocrinology 119:1768-1775
27. Ingber DE, Fujita T, Kishimoto S, Sudo K, Kanamaru T, Brem H, Folkman J (1990) Synthetic analogues of fumagillin that in-hibit angiogenesis and suppress tumor growth. Nature 348: 555-557
28. Inokuchi J, Masayuki J, Momosaki K, Shimeno H, Nagamatsu A, Radin N (1990) Inhibition of experimental metastasis of murine Lewis lung carcinoma by an inhibitor of glucosylceramide synthase and its possible mechanism of action. Cancer Res 50:6731-6737
29. Isoai A, Giga-Hama Y, Shinkai K, Mukai M, Akedo H, Kumagai H (1990) Purification and characterization of tumor invasion-inhibiting factors. Jpn J Cancer Res 81:909-914
30. Isoai A, Gigo-Hama Y, Shinkai K, Mukai M, Akedo H, Kumagai H (1992) Tumor invasion-inhibiting factor 2: primary structure and inhibitory effect on invasion in vitro and pulmonary metastasis of tumor cells. Cancer Res 52:1422-1426
31. Isoai A, Goto-Tsukamoto H, Murakami K, Akedo H, Kumagai H (1993) A potent antimetastatic activity of tumor invasion-inhibiting factor-2 and albumin conjugate. Biochem Biophys Res Commun 192:7-14
32. Ito K, Abe T, Tomita M, Morimoto A, Kohno K., Mori T, Ono M, Sugenoya A, Nishihira T, Kuwano M (1993) Anti-angiogenic activity of arachidonic acid metabolism inhibitors in angiogenesis model systems involving human microvascular endothelial cells and neovascularization in mice. Int J Cancer 55: 660-666
33. Julius D, Livelli T, Jessell T, Axel R (1989) Ectopic expression of the serotonin le receptor and triggering of malignant transformation. Science 244: 1057-1062
34. Kandel J, Bossy-Wetzel E, Radvanyi F, Klagsbrun M, Folkman J, Hanahan D (1991) Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma. Cell 66:1095-1104
35. Kim KJ, Li B, Winer J, Armanini M, Gillett N, Phillips HS, Ferrara N (1993) Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 362:841-844
36. Kobayashi H, Hidekazu O, Sugimura M, Shinohara H, Fujii T, Terao T ( 1992) Inhibition of in vitro ovarian cancer cell invasion by modulation of urokinase-type plasminogen activator and cathepsin B. Cancer Res 52:3610-3614
37. Kobayashi H, Shinohara H, Takeuchi K, Itoh M, Fujie M, Saitoh M, Terao T (1994) Inhibition of the soluble and the tumor cell receptor-bound plasmin by urinary trypsin inhibitor and subsequent effects on tumor cell invasion and metastasis. Cancer Res 54:844-849
38. Koch AE, Cho M, Burrows J, Leibovich SJ, Polverini PJ ( 1988) Inhibition of production of macrophage-derived activity by the antirheumatic agents gold sodium thiomalate and auranofin. Biochem Biophys Res Commun 154:205-212
39. Kohga S, Harvey SR, Weaver RM, Markus G (1985) Localization of plasminogen activators in human colon cancer by immunoperoxidase staining. Cancer Res 45:1787-1796
40. Kohn EC, Liotta LA (1990) L651582: a novel antiproliferative and antimetastasis agent. J Natl Cancer Inst 82:54-60
41. Kohn EC, Felder CC. Jacobs W, Holmes K, Day A, Freer R (1994) Structure-function analysis of signal and growth inhibition by carboxyamido-triazole, CAI. Cancer Res 54:935-942
42. Laferte S, Fukuda MN. Fukuda N, Dell A, Dennis JW (1987) Glycosphingolipids of lectin-resistant mutants of the highly metastatic mouse tumor cell line, MDAY-D2. Cancer Res 47:150-159
43. Leone A. Flatow U, King CR, Sandeen M, Margulies I, Liotta LA, Steeg PS (1991) Reduced tumour incidence, metastatic potential and cytokine responsiveness of nm23 transfected melanoma cells. Cell 65:25-35
44. Leyton J, Manyak A. Mukherjee A, Miele L, Mantile G, Patierno S (1994) Recombinant human uteroglobin inhibits the in vitro invasiveness of human metastatic prostate tumor cells and the release of arachidonic acid stimulated by fibroblastconditioned medium. Cancer Res 54:3696-3699
45. Liotta LA ( 1986) Tumor invasion and metastasis - role of the extracellular matrix: Rhodes Memorial Award lecture. Cancer Res 46: 1-7
46. Liotta LA, Kleinerman J, Saidel GM (1974) Quantitative relationship of intravascular tumor cells, tumor vessels and pulmonary métastases following tumor implantation. Cancer Res 34:997-1004
47. Liotta LA, Mandler R, Murano G, Katz DA, Gordon RK, Chiang PK, Schiffman E (1986) Tumor cell autocrine motility factor. Proc Natl Acad Sci USA 83:3302-3306
48. Liotta LA, Stetler Stevenson WG (1991) Tumour invasion and metastasis: an imbalance of positive and negative regulation. Cancer Res 51 (Suppl): 5054-5059
49. Maione TE, Gray CS, Hunt A, Sharpe RJ (1991) Inhibition of tumor growth in mice by an analogue of platelet factor 4 that lacks affinity for heparin and retains potent angiostatic activity. Cancer Res 51:2077-2083
50. Maragoudakis ME, Sarmonika M, Panoutsacopoulou M (1989) Antiangiogenic action of heparin plus cortisone is associated with decreased collagenous protein synthesis in the chick chorioallantoic membrane system. J Pharmacol Exp Ther 251 : 679-682
51. McGregor BC, McGregor JL, Weiss LM, Wood GS, Hu CH, Boukerche H, Warnke RA (1989) Presence of cytoadhesins (Ilb-IIIa-like glycoproteins) on human metastatic melanomas but not on benign melanocytes. Am J Clin Pathol 92:495-41-99
52. Moses MA, Sudhalter J, Langer R (1990) Identification of an inhibitor of neovascularization from cartilage. Science 248: 1408-1410
53. Nakamori S, Kameyama M, Irnaoka S, Furukawa H, Kabuto T, Ishikawa O, Sasaki Y, Iwanaga T, Matsushita Y, Irimura T (1993) Increased expression of sialyl Lewis x antigen correlates with poor survival in patients with colorectal carcinoma: clinicopathological and immunohistochemical study. Cancer Res 53:3632-3637
54. Netland PA, Zetter BR (1989) Tumour-cell interactions with blood vessels during cancer metastasis. In: Goldfarb RH (ed) Fundamental aspects of cancer. Kluwer, Dordrecht, pp 84-97
55. Nicolson GL (1988) Organ specificity of tumour metastasis: role of preferential adhesion, invasion and growth of malignant cells at specific secondary sites. Cancer Metastasis Rev 7: 143188
56. Nicolson GL (1989) Metastatic tumor cell interactions with endothelium, basement membrane and tissue. Curr Opin Cell Biol 1:1009-1019
57. Oikawa T, Hirotani K, Ogasawara H, Katayama T, Nakamura O, Iwaguchi T, Hiragun A (1990) Inhibition of angiogenesis by vitamin D3 analogues. Eur J Pharmacol 178:247-250
58. Orchard PJ, Smith CM III, Woods WG, Daly DB, Dehner LP, Shapiro R (1989) Treatment of haemangioendotheliomas with alpha interferon. Lancet II : 565-567
59. Ostrowski LE, Finch J, Krieg P, Matrisian L, Patskan G, O'Connell JF, Phillips J, Slaga TJ, Breathnach R, Bowden GT (1988) Expression pattern of a gene for a secreted metalloproteinase during late stages of tumor progression. Mol Carcinog 1:13-19
60. Peng YM, Dalton WS, Alberts DS, Xu MJ, Lim H, Meyskens FL (1989) Pharmacokinetrcs of/V-4-hydroxyphenyl-retinamide and the effect of its oral administration on plasma retinol concentrations in cancer patients. Int J Cancer 43:22-26
61. Pienta KJ, Nguyen NM, Lehr JE (1993) Treatment of prostate cancer in the rat with synthetic retinoid fenretinide. Cancer Res 53:224-226
62. Pollard M, Luckert PH (1981) Effect of indomethacin on intestinal tumors induced in rats by the acetate derivative of dimethylnitrosamine. Science 214:558-559
63. Pollard M, Luckert PH, Spom MB (1991) Prevention of primary prostate cancer by /V-4-hydroxyphenyl retinamide. Cancer Res 51:3610-3611
64. Rastinejad F, Polverini PJ, Bouck NP (1989) Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene. Cell 56:345-355
65. Reich R, Thompson E, Iwamoto Y, Martin OR, Deason JR, Fuller GC, Miskin R (1988) Effects of inhibitors of plasmino-gen activator, serin proteinases, and collagenase IV on the invasion of basement membranes by metastatic cells. Cancer Res 48:3307-3312
66. Rice GE, Bevilacqua MP ( 1989) An inducible endothelial surface glycoprotein mediates melanoma adhesion. Science 246: 1303-1306
67. Rigau J, Pique JM, Rubio E, Planas R, Tarrech JM, Bordas JM (1991) Effects of long-term sulindac therapy on colonie polyposis. Ann Intern Med 115:952-954
68. Rochefort H (1990) Cathepsin D in breast cancer. Breast Cancer Res Treat 16:3-13
69. Rolland P, Martin P, Jacquemier J, Rolland A, Toga M (1980) Prostaglandin in human breast cancer: evidence suggesting an elevated prostaglandin production is a marker of high metastatic potential for neoplastic cells. J Natl Cancer Inst 64:1061 1070
70. Saiki I, lida J, Murata J, Ogawa R, Nishi N, Sugimura K, Tokura S, Azuma I (1989) Inhibition of the metastasis of murine malignant melanoma by synthetic polymeric peptides containing core sequences of cell-adhesive molecules. Cancer Res 49:3815-3822
71. Sawada R, Tsuboi S, Fukuda M (1994) Differential E-selectindependent adhesion efficiency in sublines of a human colon cancer exhibiting distinct metastatic potentials. J Biol Chem 269:1425-1431
72. Scott PA, Harris AL (1994) Current approaches to targeting cancer using antiangiogenesis therapies. Cancer Treat Rev 20 : 393-412
73. Simon M, Strathmann M, Gautam N (1991) Diversity of Ci proteins in signal transduetion. Science 252:802-808
74. Stearns ME. Wang M (1993) Type IV collagenase (Mr 72,000) expression in human prostate benign and malignant tissue. Cancer Res 53:878-883
75. Tamargo RJ, Bok RA. Brem H (1991) Angiogenesis inhibition by minocycline. Cancer Res 51 :672-675
76. Tsuboi R, Rifkin DB (1990) Bimodal relationship between invasion of the amniotic membrane and plasminogen activator activity. Int J Cancer 46:56-60
77. Tubiana M, Chauvel P, Malaise EP (1975) Growth rate and natural history of human breast cancer. Bull Cancer 62:341358
78. Turpeenniemi-Hujanen T, Thorgeirsson UP, Rao CN, Liotta L (1986) Laminin increases the release of type IV collagenase from malignant cells. J Biol Chem 261 :1883-1889
79. Wang M, Stearns ME (1988) Blocking of collagenase secretion by estamustine during in vitro tumor cell invasion. Cancer Res 48:6262-6271
80. Wilks JW, Scott PS, Vrba LK, Cocuzza JM (1991) Inhibition of angiogenesis with combination treatments of angiostatic steroids and suramin. Int J Radiât Biol 60:73-77
81. Yamaoka M, Yamamoto T, Ikeyama S, Sudo K, FujitaT (1993) Angiogenesis inhibitor TNP-470 (AGM 1470) potently inhibits the tumor growth of hormone-independent human breast and prostate carcinoma cell lines. Cancer Res 53:5233-5236